CN1194844A - Chinese patent medicine for curing cerebrovascular disease - Google Patents

Chinese patent medicine for curing cerebrovascular disease Download PDF

Info

Publication number
CN1194844A
CN1194844A CN97103837A CN97103837A CN1194844A CN 1194844 A CN1194844 A CN 1194844A CN 97103837 A CN97103837 A CN 97103837A CN 97103837 A CN97103837 A CN 97103837A CN 1194844 A CN1194844 A CN 1194844A
Authority
CN
China
Prior art keywords
radix
chinese patent
patent medicine
cerebrovascular disease
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN97103837A
Other languages
Chinese (zh)
Other versions
CN1049351C (en
Inventor
黄肇源
黄丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN97103837A priority Critical patent/CN1049351C/en
Publication of CN1194844A publication Critical patent/CN1194844A/en
Application granted granted Critical
Publication of CN1049351C publication Critical patent/CN1049351C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese patent medicine for curing cerebrovascular diseases such as cerebral embolism, cerebral hemorrhage, subarachnoid hemorrhage and encephalatrophy is prepared from 18 Chinese-medicinal materials such as astragalus root, pilose asiabell root, fleece flower root, wolfberry fruit, longan aril, etc., and features higher curative effect.

Description

A kind of Chinese patent medicine for the treatment of cerebrovascular disease
The present invention relates to a kind of Chinese patent medicine for the treatment of cerebrovascular disease, specifically be to be active ingredient with the Chinese herbal medicine, the Chinese patent medicine that is prepared from, this medicine are to cerebral thrombosis, and diseases such as cerebral embolism, cerebral hemorrhage, subarachnoid hemorrhage, brain atrophy have treatment and preventive effect.
At present, both at home and abroad, adopt following several method usually: 1. microcirculation improvement therapy to the treatment of cerebrovascular disease.The intravenous drip low molecular dextran can the cerebral blood flow increasing amount, because this medicine can increase intracranial pressure and cardiac output, patient's forbidding of intracranial hypertension and heart failure is arranged.For the use of carboxymethylamylum natrium vasodilations such as (carboxymethyl starch sodium), medical circle exists dispute, and the someone thinks and can cause " the interior blood of stealing of brain " phenomenon, cause intracranial hypertension, may enlarge hemorrhagic focus to red infarct person; 2. antithrombotic therapy.Generally be to use anticoagulant, still disputable so far to this therapy medical circle, part scholar advocates that the method is only applicable to the infraction of vertebral-basilar artery system, and everyly has the patient of bleeding tendency, ulcer medical history, serious hypertension and liver, kidney disease to forbid anticoagulant.Because cerebrovascular disease patient major part is all with a series of complication such as hyperlipidemia, hypertension, the use of anticoagulant must be overcautious and indecisive.The cerebrovascular disease patient has hemorrhagely, is exactly thrombosis, so use hemorrhage and coagulant is controversial Therapeutic Method, it is generally acknowledged cerebral hemorrhage is not had therapeutic value.Other Therapeutic Method has: use cerebral metabolism activator (as cytochrome C, adenosine triphosphate, r one cruel propylhomoserin etc.), cerebral protective agent (as vitamin E, preceding driffractive ring element, nimodipine etc.); hyperbaric oxygen chamber therapy; but because these therapy effects are general, so only as complementary therapy.Operative therapy is because the difficulty height, and will be subjected to the restriction of diseased region, the order of severity.Therefore, we can say, develop the above-mentioned cerebrovascular disease of a kind of effective treatment and the medicine of nontoxic pair of effect is one of important topic of medical circle for the treatment of cerebrovascular disease ideal especially medicine not also.
The pure Chinese medicinal preparation that the purpose of this invention is to provide a kind of effective treatment cerebrovascular disease and nontoxic pair of effect.
The diseased region of cerebrovascular disease is at brain, and according to the determining the pathogenesis of ZANG-FU disease based on the differentiation of symptoms and signs theory of theory of Chinese medical science, it is positioned at kidney, and the cause of disease is that internal organs are deficient, yin or yang excessly declines partially, and its pathogenesis is a simulataneous insufficiency and excessive, clinically with deficiency of the kidney, stasis of blood resistance venation two diseases and see.On pathology, encephalopathy can reach dirty, and disease of ZANG-organs also can reach brain; Deficiency of marrow-reservoir is a deficiency in origin, and phlegm-turbidity and blood stasis blood is violated brain and resembled for mark.Internal organs are deficient, empty sun with on general, expectorant turbid with on general, stop up the key road, cause cerebrovascular disease, cause that stiff tongue can not speak, foot is useless can not be walked.Since the deficiency of both YIN and YANG of kidney, kidney governing bones, so the muscles and bones flaccidity is soft unable, the shakiness of standing, walk, the walking of leaning forward, walk haltingly, walking must the people be assisted in, the severe patient general paralysis, gatism be can't take care of oneself.The kidney meridian arteries and veins hold under the arm tongue this, the vital essence of suffering from a deficiency of the kidney then can not on hold, in addition expectorant turbid general, stop up the key road, brain must not be supported, patient's dull expression, bradykinesia, giddy, stiff tongue, sialorrhea, frequent micturition, hypomnesis, abstract thinking and disorientation are gone down with social ability.This type of disease is taken the photograph to receive and is had no right all because of the deficiency of both YIN and YANG of kidney, and the rule of treatment is for tonifying Qi of the kidney, and foster essence is filled out marrow, activating blood circulation and dissipating phlegm, refreshment.
According to above-mentioned legislation principles, prescription composed as follows (weight portion)
Radix Astragali 10-20 part
Radix Codonopsis 10-20 part
Radix Polygoni Multiflori 10-20 part
Fructus Lycii 10-20 part
Arillus Longan 10-20 part
Rhizoma Dioscoreae 10-20 part
Radix Angelicae Sinensis 10-20 part
Rhizoma Acori Graminei 5-15 part
Radix Polygalae 5-15 part
Fructus Alpiniae Oxyphyllae 5-15 part
Radix Morindae Officinalis 5-15 part
Radix Salviae Miltiorrhizae 5-15 part
Fructus Corni 5-15 part
Semen Cuscutae 5-15 part
Rhizoma Gastrodiae 5-15 part
Radix Rehmanniae Preparata 15-25 part
Concha Margaritifera 25-35 part
Herba Eupatorii 5-15 part
Radix Rehmanniae Preparata, Fructus Alpiniae Oxyphyllae, Radix Morindae Officinalis, benefiting kidney-essence in the side, Rhizoma Acori Graminei and Radix Polygalae, Rhizoma Dioscoreae medicine share, the function inducing resuscitation and resolving phlegm, the Radix Astragali, Radix Codonopsis tonification vital qi, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis two medicines share, and promoting the circulation of blood, invigorate blood circulation, nourish blood, Rhizoma Gastrodiae, Semen Cuscutae, Fructus Corni, Concha Margaritifera, Herba Eupatorii invigorating the liver and kidney, calm the nerves, about the traffic, Liver and kidney must be mended, and brain then is able to acute hearing.The kidney meridian arteries and veins hold under the arm tongue this, following unit is mended, is able to tongue and is subjected to, so stiff tongue, sialorrhea, frequent micturition symptom all remove.
Medicine of the present invention is to be composition with above-mentioned prescription, chooses raw material according to described weight proportion, with conventional formulation technology, is prepared into the various dosage forms that are suitable for clinically.
The preferred Rhizoma dioscoreae of Rhizoma Dioscoreae in the above-mentioned prescription.
According to the preparation process of routine, medicine of the present invention can be prepared into pill, unguentum, powder, tablet, oral liquid, powder, injection, capsule etc.
The preferred dosage form of medicine of the present invention is a pill, and the preparation method of pill is:
Choose raw medicinal material according to the prescription consumption, select totally, mix, oven dry is ground into fine powder, crosses 100 mesh sieves, adds refined honey and makes honeyed pill, and every ball weighs 9 grams.
Medicine of the present invention can be used for prevention and treats multiple cerebrovascular disease, and cerebral thrombosis, cerebral embolism, cerebral hemorrhage, brain atrophy are had excellent curative.
Model case:
1, Di Wenxuan: 87 years old retired employees of man, JIUYUE in 1991 first visit on the 4th suffers from hypertension history, and through CT examination, the bilateral brain stops up symmetry expansion bilateral and splits pond expansion, the broadening of bilateral volume subarachnoid space, conclusion " brain atrophy ".
Symptom: dull expression, bradykinesia, hypomnesis, walking is unstable, and sialorrhea frequent micturition enlarged tongue is and dark violet, and thick fur is white, deep-thready pulse, card belong to deficiency of the kidney, the resistance of the brain network stasis of blood, through take medicine of the present invention after ten days self-induction stand steadily, bicker sialorrhea no longer after January, urine can automatic control, again through being taken after mixing with liquid medicine of the present invention January, walking is quick on the draw freely, can go the morning market stroll every day voluntarily, buy vegetables, after follow up a case by regular visits to so far recurrence again.
2, Qiu Yonggui: man 76 years old, No. 18, Carassius auratus street, Jining City, Shandong Province, on March 14th, 94 sudden faint, rescue through city hospital, treatment back symptom: the general paralysis gatism, after various big hospital treatment unsatisfactory curative effect was treated to here on October 13rd, 94 through taking medicine of the present invention 7 days, arm is active, hotness is arranged simultaneously, through being taken after mixing with liquid medicine of the present invention after January, assisting in and can walk again through the people, the automatic control of defecation energy, after obeying January again, walk freely, the while whey-face is gain color also, especially skin is also more and more delicate, and the sense of rejuvenation is quite arranged.
Embodiment:
Prescription:
The Radix Astragali: 15 grams
Radix Codonopsis: 15 grams
Radix Polygoni Multiflori: 15 grams
Fructus Lycii: 15 grams
Arillus Longan: 15 grams
Rhizoma dioscoreae: 15 grams
Radix Angelicae Sinensis: 15 grams
Rhizoma Acori Graminei: 10 grams
Radix Polygalae: 10 grams
Fructus Alpiniae Oxyphyllae: 10 grams
Radix Morindae Officinalis: 10 grams
Radix Salviae Miltiorrhizae: 10 grams
Fructus Corni: 10 grams
Semen Cuscutae: 10 grams
Rhizoma Gastrodiae: 10 grams
Radix Rehmanniae Preparata: 20 grams
Concha Margaritifera: 30 grams
Herba Eupatorii: 9 grams
Fine powder is selected totally, dried, mixes, is ground into to said medicine, cross 100 mesh sieves, add refined honey and make pill, every ball weighs 9 grams.

Claims (2)

1, a kind of Chinese patent medicine for the treatment of cerebrovascular disease is characterized in that it is the medicament made from following pharmaceutical composition:
The Radix Astragali: 10-20 part
Radix Codonopsis: 10-20 part
Radix Polygoni Multiflori: 1-20 part
Structure Fructus Lycii: 10-20 part
Arillus Longan: 10-20 part
Rhizoma Dioscoreae: 10-20 part
Radix Angelicae Sinensis: 10-20 part
Rhizoma Acori Graminei: 5-15 part
Radix Polygalae: 5-15 part
Fructus Alpiniae Oxyphyllae: 5-15 part
Radix Morindae Officinalis: 5-15 part
Radix Salviae Miltiorrhizae: 5-15 part
Fructus Corni: 5-15 part
Semen Cuscutae: 5-15 part
Rhizoma Gastrodiae: 5-15 part
Radix Rehmanniae Preparata: 15-25 part
Concha Margaritifera: 25-35 part
Herba Eupatorii: 5-15 part
2,, it is characterized in that said medicament is a pill according to the Chinese patent medicine of claim 1.
CN97103837A 1997-04-03 1997-04-03 Chinese patent medicine for curing cerebrovascular disease Expired - Fee Related CN1049351C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN97103837A CN1049351C (en) 1997-04-03 1997-04-03 Chinese patent medicine for curing cerebrovascular disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN97103837A CN1049351C (en) 1997-04-03 1997-04-03 Chinese patent medicine for curing cerebrovascular disease

Publications (2)

Publication Number Publication Date
CN1194844A true CN1194844A (en) 1998-10-07
CN1049351C CN1049351C (en) 2000-02-16

Family

ID=5166915

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97103837A Expired - Fee Related CN1049351C (en) 1997-04-03 1997-04-03 Chinese patent medicine for curing cerebrovascular disease

Country Status (1)

Country Link
CN (1) CN1049351C (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101985000A (en) * 2010-10-25 2011-03-16 程如新 Thrombus Chinese patent oral medicine
CN105560839A (en) * 2016-02-16 2016-05-11 李敏 Medicine for treating hemorrhagic apoplexy
CN105727033A (en) * 2016-03-30 2016-07-06 广州暨南生物医药研究开发基地有限公司 Folium artemisiae argyi containing pharmaceutical preparation for treating spontaneous subarachnoid hemorrhage (SAH)
CN106139035A (en) * 2016-08-25 2016-11-23 望虎山 Treat brain atrophy, senile dementia and the Chinese medicine of cerebral infarction and preparation thereof and application
CN106334085A (en) * 2016-10-21 2017-01-18 代立新 Traditional Chinese medicine for treating brain atrophy and manufacturing method
CN108578649A (en) * 2018-07-27 2018-09-28 张俊亚 The Chinese medicine and preparation method and application for the treatment of encephalatrophy, senile dementia and cerebral infarction

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101884758B (en) * 2009-05-15 2012-04-18 天津太平洋制药有限公司 Food therapy preparation for preventing and treating cerebrovascular diseases based on theories of preventive treatment of disease and medicine food homology

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101985000A (en) * 2010-10-25 2011-03-16 程如新 Thrombus Chinese patent oral medicine
CN105560839A (en) * 2016-02-16 2016-05-11 李敏 Medicine for treating hemorrhagic apoplexy
CN105727033A (en) * 2016-03-30 2016-07-06 广州暨南生物医药研究开发基地有限公司 Folium artemisiae argyi containing pharmaceutical preparation for treating spontaneous subarachnoid hemorrhage (SAH)
CN106139035A (en) * 2016-08-25 2016-11-23 望虎山 Treat brain atrophy, senile dementia and the Chinese medicine of cerebral infarction and preparation thereof and application
CN106334085A (en) * 2016-10-21 2017-01-18 代立新 Traditional Chinese medicine for treating brain atrophy and manufacturing method
CN108578649A (en) * 2018-07-27 2018-09-28 张俊亚 The Chinese medicine and preparation method and application for the treatment of encephalatrophy, senile dementia and cerebral infarction

Also Published As

Publication number Publication date
CN1049351C (en) 2000-02-16

Similar Documents

Publication Publication Date Title
CN102240380B (en) Traditional Chinese medicine preparation for treating senile vascular dementia
CN103372135B (en) Chinese medicinal composition treating cardiovascular and cerebrovascular diseases caused by heart-kidney imbalance
CN1091609C (en) Tincture for treating rheumatoid arthritis and its preparing process
CN1112836A (en) Meicinal prepn. "Kexianling" for curing epilepsy
CN1049351C (en) Chinese patent medicine for curing cerebrovascular disease
CN102274417B (en) Chinese prepared medicament for treating aplastic anemia
CN1054528C (en) Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin"
CN1117582C (en) medicine for treating rheumatoid arthritis and preparing process thereof
CN1389255A (en) Composite Chinese medicine for treating rheumarthritis and rheumatoid arthritis
CN1413722A (en) Chinese patent drug for treating thrombus obliterating angiitis
CN1051471C (en) Drug composition for curing osteoporosis
CN100386106C (en) Medicine for treating acne and its preparation
CN1081888A (en) Treatment commonly encountered diseases of internal department, the apoplexy of frequently-occurring disease and the Chinese patent medicine tablet of sequela
CN1259065C (en) Chinese medicinal preparation for quick bone fracture setting
CN1245197C (en) Chinese medicine preparation for treating coronary heart disease and viral myocarditis
CN1142968A (en) Traditional Chinese medicine preparation for curing cervical and lumbar hyperosteogeny
CN1872236A (en) Medication for treating aplastic anemia
CN1128667A (en) Thrombus-eliminating pills
CN1275618C (en) Chinese medicinal composition for treating sexual dysfunction
CN103585414A (en) Pharmaceutical composition for treating sciatica and osteoporosis
CN1188152C (en) Composite Chinese medicine for treating protrusion of lumber interverterbral disc
CN106177141A (en) A kind of Chinese medicine of passage, nourishing blood and preparation method thereof
CN1256142C (en) Chinese medicine for treating side reaction caused by insanity resisting medicine and its preparation method
CN1115160C (en) Orally-applied medicine for treating hyperosteogeny
CN1113667C (en) Medicine for treating rheumatic and rheumatoid diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20000216

Termination date: 20160403